How do you tell the story of clean meat, sustainable fashion, brewed buildings, carbon recyclables, consumer care, and skiing? At first glance, it’s not obvious how these products fit in the same narrative. But a closer look shows that the thread weaving them all together is biology, or at least it will be if these products can succeed as biotech innovations. At SynBioBeta’s Brands and Biology event, entrepreneurs and innovators gathered from across the synthetic biology space to debate and develop solutions to the challenge of bringing biotech to consumers.During the two-day virtual conference, current and future biotechnology leaders discussed the growing intersection of consumer branding and synthetic biology, and what it will take to appeal to new consumer bases. As emerging, disruptive biotech gains traction in consumer markets, how will companies and customers alike adapt to this new product space?
The event kicked off with a discussion introducing the biggest question facing the bio-economy— Consumer Biotechnology - Why Now?The conversation centered around major marketing shifts to focus more on the consumer rather than the technology. Massimo Portincaso (Boston Consulting Group) said companies must not only deliver a functional component for their customers, they must also offer a genuine emotional narrative and customer interaction. Alexander Lorestani (Geltor) agreed, even though his company is mostly focused on supplying B2B bio-designed proteins. “One of the first things I do when new Geltor products launch is to look at the product review,” says Lorestani. What consumers say about the end product matters at all levels of the supply chain.The speakers, which also included Mikah Coffindaffer (Procter & Gamble) stressed that companies cannot mishandle their new market opportunities. With the potential to disrupt current manufacturing processes for cosmetics, fashion, and more, the key to success depends on how companies manage public reception to synthetic biology.It’s clear that consumer biotech companies must reach out to their customers through effective communication, adequate technical education, and wide appeal of their products. Coffindaffer noted that, in P&G’s trials, the purity and efficacy of bio-based cosmetics excited both regulatory partners and consumers despite the complex science and higher price point. Portincaso also emphasized that companies must be thoughtful and tread carefully to succeed in the mass market: “We don’t want the same negative narrative that GMOs got,” he says. While it may take years for these innovations to become normalized for the general public, the synthetic biology industry needs to work together to build rapport and acceptability of new brands.
For years, the scientific community has been applauded for “creating conversations.” Yet, in a discussion about GMOs after her panel, Christina Agapakis (Ginkgo Bioworks) pointed out that for the average person, “ conversation around sticky problems until it’s in front of their face,” such as bright GMO labels at the grocery store. To date, biotech companies have made very little headway with consumers by focusing only on their science.Instead, biotech companies should also be creating brands.
When synthetic biology companies make brands, they learn to speak the same language as the consumers they’re trying to reach. A brand is a mission to identify with. Consumers can connect more strongly with brands that take pride in their technology and sustainability goals, including biotech backed by GMOs. Or, as Coffindaffer puts it, “Made by nature, perfected by science.” It’s not just a catchphrase. Coffindaffer adds that “bringing to life the tagline, the naming, and the visual space will be critical.”It’s all well and good to discuss lofty hopes for consumer relations to synthetic biology. But how is this future technically achieved? During Brands and Biology, three major themes emerged:
Genuine companies are appreciated everywhere. When biotech companies talk about changing the genetic code of life, transparency is even more critical. It’s more than setting the bar for bioethics. Consumers are looking for—and lacking—transparency in science and Big Tech. The synthetic biology industry has a chance to fill that vacuum.One way to set the transparency standard is through product labeling. Companies should use the terminology that best fits their brand. But many speakers stressed that biotech companies using non-GMO labeling hinder progress and spread distrust in synthetic biology.
Follow me on LinkedIn. Check out my website.
Originally published on Forbes: https://www.forbes.com/sites/johncumbers/2020/12/08/building-customer-awareness-for-the-next-biotech-startup-lessons-from-brands--biology/?sh=361b946143b5
How do you tell the story of clean meat, sustainable fashion, brewed buildings, carbon recyclables, consumer care, and skiing? At first glance, it’s not obvious how these products fit in the same narrative. But a closer look shows that the thread weaving them all together is biology, or at least it will be if these products can succeed as biotech innovations. At SynBioBeta’s Brands and Biology event, entrepreneurs and innovators gathered from across the synthetic biology space to debate and develop solutions to the challenge of bringing biotech to consumers.During the two-day virtual conference, current and future biotechnology leaders discussed the growing intersection of consumer branding and synthetic biology, and what it will take to appeal to new consumer bases. As emerging, disruptive biotech gains traction in consumer markets, how will companies and customers alike adapt to this new product space?
The event kicked off with a discussion introducing the biggest question facing the bio-economy— Consumer Biotechnology - Why Now?The conversation centered around major marketing shifts to focus more on the consumer rather than the technology. Massimo Portincaso (Boston Consulting Group) said companies must not only deliver a functional component for their customers, they must also offer a genuine emotional narrative and customer interaction. Alexander Lorestani (Geltor) agreed, even though his company is mostly focused on supplying B2B bio-designed proteins. “One of the first things I do when new Geltor products launch is to look at the product review,” says Lorestani. What consumers say about the end product matters at all levels of the supply chain.The speakers, which also included Mikah Coffindaffer (Procter & Gamble) stressed that companies cannot mishandle their new market opportunities. With the potential to disrupt current manufacturing processes for cosmetics, fashion, and more, the key to success depends on how companies manage public reception to synthetic biology.It’s clear that consumer biotech companies must reach out to their customers through effective communication, adequate technical education, and wide appeal of their products. Coffindaffer noted that, in P&G’s trials, the purity and efficacy of bio-based cosmetics excited both regulatory partners and consumers despite the complex science and higher price point. Portincaso also emphasized that companies must be thoughtful and tread carefully to succeed in the mass market: “We don’t want the same negative narrative that GMOs got,” he says. While it may take years for these innovations to become normalized for the general public, the synthetic biology industry needs to work together to build rapport and acceptability of new brands.
For years, the scientific community has been applauded for “creating conversations.” Yet, in a discussion about GMOs after her panel, Christina Agapakis (Ginkgo Bioworks) pointed out that for the average person, “ conversation around sticky problems until it’s in front of their face,” such as bright GMO labels at the grocery store. To date, biotech companies have made very little headway with consumers by focusing only on their science.Instead, biotech companies should also be creating brands.
When synthetic biology companies make brands, they learn to speak the same language as the consumers they’re trying to reach. A brand is a mission to identify with. Consumers can connect more strongly with brands that take pride in their technology and sustainability goals, including biotech backed by GMOs. Or, as Coffindaffer puts it, “Made by nature, perfected by science.” It’s not just a catchphrase. Coffindaffer adds that “bringing to life the tagline, the naming, and the visual space will be critical.”It’s all well and good to discuss lofty hopes for consumer relations to synthetic biology. But how is this future technically achieved? During Brands and Biology, three major themes emerged:
Genuine companies are appreciated everywhere. When biotech companies talk about changing the genetic code of life, transparency is even more critical. It’s more than setting the bar for bioethics. Consumers are looking for—and lacking—transparency in science and Big Tech. The synthetic biology industry has a chance to fill that vacuum.One way to set the transparency standard is through product labeling. Companies should use the terminology that best fits their brand. But many speakers stressed that biotech companies using non-GMO labeling hinder progress and spread distrust in synthetic biology.
Follow me on LinkedIn. Check out my website.
Originally published on Forbes: https://www.forbes.com/sites/johncumbers/2020/12/08/building-customer-awareness-for-the-next-biotech-startup-lessons-from-brands--biology/?sh=361b946143b5